Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

U-Neuron Biomedical Inc (6973) Financial Statements

U-Neuron Biomedical Inc Financial Overview

U-Neuron Biomedical Inc's market cap is currently NT$2.32B. The company's EPS TTM is NT$-1.56; its P/E ratio is -35.96; U-Neuron Biomedical Inc has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 82.66MNT$ 46.21MNT$ 27.02MNT$ 26.79MNT$ 28.42M
Gross ProfitNT$ 55.39MNT$ 37.93MNT$ 21.56MNT$ 21.58MNT$ 23.93M
Operating IncomeNT$ -65.18MNT$ -68.96MNT$ -90.32MNT$ -43.68MNT$ -15.07M
EBITDANT$ -50.66MNT$ -51.45MNT$ -77.87MNT$ -36.53MNT$ -9.62M
Net IncomeNT$ -55.29MNT$ -59.97MNT$ -84.89MNT$ -43.17MNT$ -11.26M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 615.47MNT$ 748.80MNT$ 475.96MNT$ 163.02MNT$ 196.53M
Total AssetsNT$ 763.51MNT$ 846.67MNT$ 523.17MNT$ 186.30MNT$ 211.38M
Total DebtNT$ 15.79MNT$ 4.90MNT$ 9.66MNT$ 4.40MNT$ 0.00
Net DebtNT$ -389.17MNT$ -112.91MNT$ -47.29MNT$ -26.61MNT$ -55.52M
Total LiabilitiesNT$ 52.42MNT$ 35.27MNT$ 31.20MNT$ 23.04MNT$ 15.94M
Stockholders' EquityNT$ 711.09MNT$ 811.40MNT$ 491.97MNT$ 163.26MNT$ 195.44M
Cash Flow
Free Cash FlowNT$ -85.58MNT$ -98.78MNT$ -55.60MNT$ -39.75MNT$ -2.51M
Operating Cash FlowNT$ -41.36MNT$ -53.92MNT$ -53.21MNT$ -36.35MNT$ -653.00K
Investing Cash FlowNT$ 373.70MNT$ -260.47MNT$ -306.45MNT$ 5.20MNT$ -88.02M
Financing Cash FlowNT$ -44.83MNT$ 375.23MNT$ 385.60MNT$ 6.65MNT$ 137.50M

Currency in TWD

U-Neuron Biomedical Inc Earnings and Revenue History

-100M0100M200M-360 %-240 %-120 %0 %EarningsProfit Margin20212022202320242025RevenueEarningsProfit Margin
Income Statement >

U-Neuron Biomedical Inc Liabilities to Assets

0300M600M900M0 %5 %10 %15 %LiabilitiesLiabilities to Assets20212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

U-Neuron Biomedical Inc Cash Flow

-400M-200M0200M400M600M20212022202320242025OperatingInvestingFinancing
Cash Flow >

U-Neuron Biomedical Inc Forecast EPS vs Actual EPS

Earnings >